相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current Treatment Options for Metastatic Head and Neck Cancer
Katharine A. R. Price et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Management of Recurrent Head and Neck Cancer Recent Progress and Future Directions
Bruce E. Brockstein
DRUGS (2011)
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent
Jacques Tortochaux et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Optimal treatment for recurrent/metastatic head and neck cancer
J. B. Vermorken et al.
ANNALS OF ONCOLOGY (2010)
Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial
Fernando Rivera et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Phase III Study of Gefitinib 250 Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck
J. Simon W. Stewart et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck
A. Dimitrios Colevas
JOURNAL OF CLINICAL ONCOLOGY (2006)
Epidermal growth factor receptor biology in head and neck cancer
Shailaja Kalyankrishna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
EEW Cohen et al.
CLINICAL CANCER RESEARCH (2005)
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study
B Burtness et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer
M Shiraki et al.
MODERN PATHOLOGY (2005)
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy
KK Ang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
B Brockstein et al.
ANNALS OF ONCOLOGY (2004)
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
EEW Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
